PPA Use, Hemorrhagic Stroke Link In Young Women Cited By NDAC
This article was originally published in The Tan Sheet
Executive Summary
The Hemorrhagic Stroke Project failed to clearly identify any population subgroups, with the exception of women, who should be advised through label warnings to avoid PPA-containing products, the Nonprescription Drugs Advisory Committee concluded at a meeting in Gaithersburg, Md. Oct. 19.